![]() | ![]() |
Formats:
|
||||||||||||||||||||||
Copyright This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original DOI. Research Air Pollution Exposures and Circulating Biomarkers of Effect in a Susceptible Population: Clues to Potential Causal Component mixtures and mechanisms 1Department of Epidemiology, School of Medicine and 2Department of Statistics, School of Information and Computer Sciences, University of California, Irvine, Irvine, California, USA 3Department of Civil and Environmental Engineering, Viterbi School of Engineering, University of Southern California, Los Angeles, California, USA 4Occupational and Environmental Medicine Division 5Nephrology and Hypertension Division and 6Cardiology Division, Department of Medicine, School of Medicine, University of California, Irvine, California, USA Address correspondence to R.J. Delfino, Department of Epidemiology, School of Medicine, University of California, Irvine, 100 Theory, Suite 100, Irvine, CA 92617 USA. Telephone: (949) 824-1767. Fax: (949) 824-1343. E-mail: rdelfino/at/uci.edu The authors declare they have no competing financial interests. Received September 16, 2008; Accepted April 29, 2009. Abstract Background Mechanisms involving oxidative stress and inflammation have been proposed to explain associations of ambient air pollution with cardiovascular morbidity and mortality. Experimental evidence suggests that organic components and ultrafine particles (UFP) are important. Methods We conducted a panel study of 60 elderly subjects with coronary artery disease living in retirement communities within the Los Angeles, California, air basin. Weekly biomarkers of inflammation included plasma interleukin-6, tumor necrosis factor-α soluble receptor II (sTNF-RII), soluble platelet selectin (sP-selectin), and C-reactive protein (CRP). Biomarkers of erythrocyte antioxidant activity included glutathione peroxidase-1 and superoxide dismutase. Exposures included outdoor home daily particle mass [particulate matter < 0.25, 0.25–2.5, and 2.5–10 μm in aerodynamic diameter (PM0.25, PM0.25–2.5, PM2.5–10)], and hourly elemental and black carbon (EC–BC), estimated primary and secondary organic carbon (OCpri, SOC), particle number (PN), carbon monoxide (CO), and nitrogen oxides–nitrogen dioxide (NOx–NO2). We analyzed the relation of biomarkers to exposures with mixed effects models adjusted for potential confounders. Results Primary combustion markers (EC–BC, OCpri, CO, NOx–NO2), but not SOC, were positively associated with inflammatory biomarkers and inversely associated with erythrocyte anti-oxidant enzymes (n = 578). PN and PM0.25 were more strongly associated with biomarkers than PM0.25–2.5. Associations for all exposures were stronger during cooler periods when only OCpri, PN, and NOx were higher. We found weaker associations with statin (sTNF-RII, CRP) and clopidogrel use (sP-selectin). Conclusions Traffic-related air pollutants are associated with increased systemic inflammation, increased platelet activation, and decreased erythrocyte antioxidant enzyme activity, which may be partly behind air pollutant–related increases in systemic inflammation. Differences in association by particle size, OC fraction, and seasonal period suggest components carried by UFP are important. Keywords: cytokines, enzymes, epidemiology, longitudinal data analysis, oxidative stress Ambient mass concentrations of particulate matter (PM) air pollution < 2.5 μm (PM2.5) and < 10 μm (PM10) in aerodynamic diameter have been associated with hospital admissions and mortality due to cardiovascular causes in time series studies (Pope and Dockery 2006). Mechanisms involving oxidative stress and inflammation have been proposed to explain these associations (Mills et al. 2007) (Figure 1
We aimed to improve the characterization of PM exposure in order to yield clues to potentially important pollutant sources and causal component mixtures not otherwise evident with ambient PM2.5 and PM10 mass, which are regulated by the U.S. Environmental Protection Agency (Delfino et al. 2005) (Figure 1 To address these questions, we conducted a panel study with repeated measurements of biomarkers and exposures in 60 elderly individuals with a history of coronary artery disease (CAD), a population potentially susceptible to adverse effects of air pollution (von Klot et al. 2005). We investigated the relationship of intensive measurements of outdoor home air pollutants to changes in circulating bio-markers of inflammation, platelet activation, and antioxidant capacity (Figure 1 Materials and Methods Population We recruited subjects from four large retirement communities in the Los Angeles (LA), California, air basin. Three were in the San Gabriel Valley, closer to downtown LA and thus closer to traffic sources, and one was further inland in Riverside, California. Eligibility criteria included a confirmed CAD history, ≥ 65 years of age, nonsmoker, and unexposed to environmental tobacco smoke. We clinically evaluated 105 potentially eligible subjects on site. Twenty-one subjects were not eligible, and 20 dropped out or had too few blood draws (< 5 of 12 weeks), leaving 64 subjects. Four subjects had insufficient biomarker data, mostly because of exclusions for frequent infections, leaving 60 subjects ≥ 71 years of age with 5–12 weekly blood draws (n = 578) (Table 1). The study protocol was approved by the Institutional Review Board of the University of California, Irvine, and we obtained informed written consent from subjects.
Two communities were studied in 2005–2006 (29 subjects) and two communities were studied in 2006–2007 (31 subjects). We studied subjects in two periods to enhance known contrasts across the LA basin in particle composition and size distribution by season (Sioutas et al. 2005). In each community, we collected 6 weeks of data during a period of higher temperature (July–mid-October), and thus higher photochemical activity and mixing depths, and 6 weeks of data during a cooler period (mid-October–February), with more frequent periods of air stagnation and lower mixing heights (when traffic-related primary air pollutants increase at ground level). Over a 7-month period, each subject was followed weekly in these two 6-week blocks with blood draws for circulating biomarkers of inflammation and antioxidant activity. Subjects completed daily diaries reporting medication use. Biomarkers Venous peripheral blood samples were drawn at the same time of day and day of week (Friday afternoons) and rapidly separated within 30 min into erythrocytes and plasma and frozen at our on-site mobile field laboratory. For the current analysis, we focused on biomarkers that were most informative in the previous analysis of first-year data (Delfino et al. 2008). Plasma samples stored at −80°C were thawed and assayed using 96-well immuno assay kits for the proinflammatory cytokines interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) (Quantikine HS, R&D Systems, Minneapolis, MN), soluble TNF-α receptor II (sTNF-RII) (Quantikine, R&D Systems), the acute-phase protein C-reactive protein (CRP) (Zymutest, Hyphen BioMed, Neuville-sur-Oise, France), and a marker of platelet activation, soluble platelet selectin (sP-selectin) (Jurk and Kehrel 2005). Frozen-thawed erythrocyte lysates were assayed spectrophotometrically for activities of two antioxidant enzymes, glutathione peroxidase-1 (GPx-1) and copper–zinc superoxide dismutase (Cu, Zn-SOD) (Cayman Chemical, Ann Arbor, MI), normalized to units per gram of hemoglobin (U/g Hb). Exposure assessment Measurement methods are more thoroughly described in the Supplemental Material (doi:10.1289/ehp.0800194.S1). Hourly outdoor home air pollutants were measured over 9 days before each blood draw as described elsewhere (Arhami et al. 2006; Polidori et al. 2007). These measurements included pollutant gases [carbon monoxide, nitrogen oxides–nitrogen dioxide (NOx–NO2), ozone], total PN (condensation particle counter model 3785; TSI Inc, Shoreview, MN), PM2.5 organic carbon (OC) and elemental carbon (EC) (OC_EC analyzer model 3F; Sunset Laboratory Inc., Tigard, OR), and black carbon (BC) (aethalometer; Magee Scientific, Berkeley, CA). We also measured size-fractionated PM mass with the Sioutas personal cascade impactor sampler (SKC, Inc., Eighty Four, PA) over 24-hr periods from mid-afternoon to mid-afternoon for 5 days before each blood draw (unlike hourly pollutants measured 9 days before). This included particles 0–0.25 μm in diameter (PM0.25), accumulation-mode particles 0.25–2.5 μm in diameter (PM0.25–2.5), and coarse mode particles 2.5–10 μm in diameter (PM2.5–10). We refer to PM0.25 as “quasi-ultrafine” because the upper size cutpoint for the ultrafine mode has varied from 0.1 to 0.2 μm, depending on locations and seasons. UFP are traditionally defined as those originating mostly from fresh emission sources and accounting for > 90% of the number-based particle concentrations (Sioutas et al. 2005). A major fraction of accumulation-mode PM originates from the ultrafine mode. This is unlike coarse particles and fine particles (PM2.5, or accumulation plus ultrafine), which are naturally divided by a cutpoint of 2.5 μm and have clearly different origins. We estimated outdoor secondary OC (SOC) and primary OC (OCpri) from total OC as detailed in our recent publication (Polidori et al. 2007) and summarized in the Supplemental Material (doi:10.1289/ehp.0800194.S1). OCpri is representative of particles emitted directly from combustion sources (mostly fossil fuels in the LA basin), whereas SOC represents semivolatile and low-volatile products of photochemical reactions involving reactive organic gases from anthropogenic and biogenic sources. The study average outdoor SOC accounted for 34% and 44% of total OC in the cooler and warmer phases, respectively. Analysis We used linear mixed-effects models to analyze relationships of biomarkers to air pollutant exposures (Verbeke and Molenberghs 2001). Because within-individual repeated measures of outcomes are correlated, random effects were estimated at the subject level, nested within phase and community. The covariance structure observed from empiric variograms was representative of an autoregressive-1 correlation, and models were fit as such. Using mean centered exposures, we adjusted for between-subject group and between-phase exposure effects. Thus, the interpretation of reported estimates is at the subject level [see Supplemental Material (doi:10.1289/ehp.0800194.S1)]. To assess more acute versus cumulative exposure–response relationships, we evaluated last 24-hr averages of air pollutants (1 day) as well as cumulative exposures up to 9 days (or 5 days for particle mass) before the blood draw. We chose a set of averaging times that skipped over averages by 1 day to simplify the presentation while still presenting a view of associations across the span of averaging times (1-day, 3-day, 5-day, 7-day, and 9-day averages). We decided a priori to exclude person-weeks with acute infectious illnesses, given their known impact on measured biomarkers. We controlled for temperature at the same averaging time as the air pollutant. We hypothesized a priori that medication variables known to influence inflammation and oxidative stress would act as effect modifiers. This included 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase inhibitors (statins), and angiotensin-converting enzyme (ACE) inhibitors or angiotensin II receptor blockers (ARB). We also tested effect modification of sP-selectin associations by clopidogrel, a platelet aggregation inhibitor. We tested differences in association by seasonal phase of study to gain clues regarding underlying differences in potentially important air pollutant components. In addition, given the known differences in air pollution in the San Gabriel Valley (three communities) compared with Riverside (one community), we tested differences in association between these regions. We planned these analyses in advance by designing the study to follow subjects during two seasonal phases and in different regions, known factors leading to differences in pollutant components and particle size distribution. All interactions (medications, phase, and group) were tested in product term models and all stratified results come from these models including all data. Associations were more strongly positive in the San Gabriel Valley (44 subjects) than in Riverside (16 subjects) for sTNF-RII and sP-selectin [see Supplemental Material (doi:10.1289/ehp.0800194.S1)]. To simplify model presentation, we show results for sTNF-RII and sP-selectin for subjects in the three San Gabriel Valley communities. We examined residual diagnostics to investigate deviations from standard linear mixed-model assumptions (functional form of independent variables and covariance assumptions) and the presence of influential observations. Four influential high outliers for IL-6 > 10 pg/mL were reset to 10 pg/mL, and one extreme influential outlier for sP-selectin (221 ng/mL) was removed to obtain more representative estimates of association. Residuals for both CRP and TNF-α exhibited a highly skewed distribution, primarily due to a cluster of subjects in the upper quartile of biomarker concentrations, and 2–3 high outliers > 3 SD above the mean. Outliers were reset to the next highest values, and secondary subgroup analyses were conducted among subjects in the upper quartile of mean CRP versus the lower three quartiles. Although this analysis was clearly data driven, similar subgroup analyses have been previously reported (Dubowsky et al. 2006; Rückerl et al. 2006). Mixed-models analyses for both CRP and TNF-α were stratified as such to show differential risk by chronic inflammation and to express results for both variables in their measured units. To identify influential subject clusters, we tested random slopes models as well as individual autoregressive models. Through this exploratory data analysis, we found that five subjects in erythrocyte Cu, Zn-SOD models and three subjects in erythrocyte GPx-1 models formed highly influential clusters with positive associations between air pollutants and biomarkers. One subject was a positive responder for both biomarkers [see Supplemental Material (doi:10.1289/ehp.0800194.S1)]. Below, we present results for secondary analyses excluding these influential subjects. Because these results stem from a sensitivity analysis, the reported results should be interpreted conservatively. Results Descriptive statistics Descriptive data for bio-marker measurements are shown in Table 2. Table 3 gives descriptive statistics for exposures by phase of study. Exposures were generally similar across the two phases, except for notably higher concentrations of OCpri, PN, and NOx in phase 2 (colder phase), and higher concentrations of SOC and O3 in phase 1 (warmer phase). High outdoor PM0.25 relative to PM2.5 are likely attributable to large impacts of local traffic in the LA basin compared with the eastern half of the nation with much larger contributions to PM2.5 from accumulation-mode sulfate aerosols. Table 4 shows exposure correlations for combined phases. EC, BC, OCpri, NOx, and CO were strongly correlated with each other, likely because they are products of fossil fuel combustion. These correlations were stronger in phase 2 than in phase 1 (data not shown). PN and PM0.25 concentrations were moderately correlated with these combustion-related pollutants, and these correlations were stronger in the three San Gabriel Valley communities closer to traffic sources than in Riverside (data not shown). There is a stronger correlation between PM0.25 and PM2.5–10 (coarse particles) than between PM0.25 and PM0.25–2.5 because PM0.25 and coarse particles come from primary traffic sources in our study region. Whereas PM0.25 is primarily a product of fresh emissions, PM0.25–2.5 is a product of aging and photo-chemical reactions.
Regression analysis Many positive associations were found for IL-6, sP-selectin, sTNF-RII, TNF-α, and CRP with markers of traffic-related air pollution (EC, OCpri, BC, NOx, and CO). We also found inverse associations of Cu, Zn-SOD and GPx-1 with the same pollutants. However, this was found only in the restricted subset of 55 (Cu, Zn-SOD) and 57 subjects (GPx-1) as presented below, whereas models including all 60 subjects were mostly nonsignificant [see Supplemental Material (doi:10.1289/ehp.0800194.S1)]. To simplify the presentation, we focus here on two biomarkers of inflammation (IL-6 and sTNF-RII) and present results for TNF-α and CRP online [see Supplemental Material (doi:10.1289/ehp.0800194.S1)]. We also present results for two key markers of primary combustion (EC and OCpri) that were strongly correlated with the other markers not shown (BC, NOx, and CO). We present pollutant averaging times here that best represent associations across the span of time rather than the full set of selected averaging times. In many but not all cases, associations were strongest for longer-term averages out to the last 5 days and, in some cases, 9 days. Regression results for all pollutants and all selected lag averages are shown online [see Supplemental Material (doi:10.1289/ehp.0800194.S1)]. Biomarkers of systemic inflammation (IL-6 and sTNF-RII), but not sP-selectin, were more strongly and significantly associated with quasi-ultrafine PM0.25 than larger-size fractions (Figure 2
Across all biomarkers, we also found consistently stronger associations for OCpri than for SOC, and this was generally reflected by confidence intervals (CIs) for total OC that usually crossed zero (Figure 3
Associations were generally stronger in phase 2 than in phase 1 for IL-6, Cu, Zn-SOD, and sP-selectin (Figure 4
Furthermore, associations were stronger among subjects not taking statins for sTNF-RII and stronger among subjects not taking clopidogrel for sP-selectin (Figure 5
As previously reported and discussed for year 1 data (Delfino et al. 2008) but not presented here, regression coefficients for ozone had opposite signs compared with other pollutants [see Supplemental Material (doi:10.1289/ehp.0800194.S1)] and were completely confounded by markers of primary combustion (EC, BC, OCpri, CO, NOx) with which O3 was inversely correlated (Table 4). Discussion Our results are largely consistent with recent repeated-measures studies showing associations between ambient air pollution and bio-markers of systemic inflammation in healthy young adults (Chuang et al. 2007) and susceptible subjects with CAD (Dubowsky et al. 2006; Rückerl et al. 2006, 2007a; 2007b; Yue et al. 2007). We extended these previous findings with data from intensive home exposure assessments and modeling that provided clues to potentially causal pollutant components. This is also the first study to show adverse effects of air pollutants on erythrocyte anti-oxidant enzymes. We focused on elucidating the role of pollutants closely associated with traffic, including EC and PM0.25. This was accomplished with extensive measurements of exposures in the immediate outdoor community microenvironments of subjects, including size-fractionated PM, OC fractions, and measurements across seasons that helped us characterize differences in response potentially due to particle size distribution and chemical composition. The approach likely enabled us to detect stronger associations with PM0.25 than PM0.25–2.5 (Figure 2 The approach also enabled us to demonstrate for the first time that associations of IL-6, sP-selectin, and SOD with PM markers of primary combustion (EC, OCpri), PN, and PM0.25 were stronger in a cooler 6-week period (phase 2) than a warmer 6-week period (phase 1) (Figure 4 Semivolatile organic components associated with particles may also have been important, given that biomarker associations were similarly robust for the correlated gases CO and NOx [see Supplemental Material (doi:10.1289/ehp.0800194.S1)]. This included generally stronger associations with gases in phase 2 than in phase 1 when NOx concentrations were lower. These gases were unlikely causal at the observed low concentrations (Devlin et al. 1999; Thom et al. 2006) but instead served as markers for other traffic emission components. Other findings support the hypothesis that effects of air pollution on cardiovascular health are secondary to proinflammatory properties of redox active and other pollutant components (Delfino et al. 2005). Associations for sTNF-RII were stronger in subjects not taking statins, which have anti-inflammatory properties. These findings are consistent with reports of weaker associations between air pollutants and CRP among statin users in two other panel studies of susceptible elderly subjects (Dubowsky et al. 2006; Rückerl et al. 2006). Our new finding for sP-selectin is consistent with a panel study showing an association of ambient UFP with another platelet activation marker (soluble CD40 ligand) in people with CAD (Rückerl et al. 2007b). Our study is the first to show a protective effect of clopidogrel. This finding supports the plausibility of a pollutant effect on platelet activation, because this medication blocks platelet aggregation and is associated with decreased sP-selectin (Xiao and Théroux 2004). Our findings are relevant to the potential for air pollution to affect CAD, because sP-selectin activates both leukocytes and endothelial cells and induces adhesion of leukocytes to platelets and to endothelial cells (Jurk and Kehrel 2005). Therefore, if air pollutants acutely activate platelets as suggested by our finding, this could increase the risk of a potentially fatal thrombotic event in the coronary arteries (Figure 1 Other novel findings are the inverse associations between air pollutants and two anti-oxidant enzymes (GPx-1 and Cu, Zn-SOD). Experimental results show that urban UFP can induce a positive antioxidant response represented by hemoxygenase-1 in epithelial and macrophage cell cultures (Li et al. 2003). However, erythrocytes do not have nuclei and thus have a relatively fixed amount of antioxidant enzymes after maturation from reticulocytes. The findings for GPx-1 and Cu, Zn-SOD in most of the elderly subjects studied suggest enzyme inactivation within erythrocytes by pollutant components or PM0.25. There is experimental evidence to support this hypothesis (Hatzis et al. 2006; Pigeolet et al. 1990; Shinyashiki et al. 2008) as well as evidence showing that quasi-UFP ≤ 0.2 μm in diameter and nanoparticles, but not larger particles, freely enter the erythrocyte (Rothen-Rutishauser et al. 2006). This may be a clue to an important pathway involving primarily UFP (Elder and Oberdörster 2006) and related organic and inorganic components that may enter the circulation to then target erythrocytes as well as other cells. Erythrocytes are critical in protecting the body against oxidative stress (Tsantes et al. 2006). Therefore, it is conceivable that erythrocyte antioxidant enzyme inactivation is partly responsible for pollutant-related increase in biomarkers of inflammation and thrombosis. This is supported by our finding of within-subject inverse associations of IL-6 with GPx-1, and sP-selectin with Cu, Zn-SOD in mixed models. For an interquartile range decrease in GPx-1 of 10.4 U/g hemoglobin, IL-6 increased 0.25 pg/mL (95% CI, −0.03 to 0.53) or 10% of mean IL-6. Similarly, for an interquartile range decrease in SOD of 2,026 U/g hemoglobin, sP-selectin increased 5.8 ng/mL (95% CI, 3.3 to 8.3), or 13% of mean sP-selectin. Biomarkers of inflammation were generally positively associated with each other, and GPx-1 was positively associated with Cu, Zn-SOD (data not shown). Furthermore, erythrocyte antioxidant enzyme inactivation may modulate the putative effects of air pollutants on endothelial dysfunction. Erythrocytes have been shown to protect cultured endothelial cells against oxidant damage. Inhibitors of either the erythrocyte glutathione system or membrane transport of superoxide into erythrocytes significantly reduced this protection (Richards et al. 1998). A small subset of subjects showed positive GPx-1 and Cu, Zn-SOD associations with air pollutants. Compared with the 53 negative responders, these seven subjects showed no notable differences in the distributions of characteristics listed in Table 1 except that none took clopidogrel and only one had a history of myocardial infarction. We speculate that these might be healthier subjects because of their ability to increase antioxidant enzyme activity, perhaps by mounting a rapid bone marrow response to PM exposure, as suggested in several experimental studies (Goto et al. 2004; Mukae et al. 2001), including increased reticulocytes (Rivero et al. 2005). In mature erythrocytes, activities of Cu, Zn-SOD and GPx-1 are steadily eroded by oxidative and nitrosative stress as they age. Consequently individuals with robust erythropoietic activity and greater proportion of newly released erythrocytes would be expected to have higher erythrocyte Cu, Zn-SOD and GPx-1 activities than sicker individuals. Study limitations include the following: Despite the biological plausibility, effect modification by medication use could have been secondary to other unmeasured characteristics of subjects. The home exposure data may be subject to exposure error because of differences with personal exposure. However, subjects stayed at home 88% of the time (from diary data). Although we believe that the present exposure data represent key sources and components, we cannot link exposure to specific sources, nor can we identify specific component classes such as polycyclic aromatic hydrocarbons as being responsible for associations. Nevertheless, the major source of fossil fuel emissions in the LA basin is motor vehicle exhaust, and because EC, BC, OCpri, CO, and NOx are linked to these emissions, our data suggest that vehicular pollutants are behind the reported associations. Conclusion Our results suggest that pollutant components linked to emission sources of primary PM2.5 OC, quasi-UFP (PM0.25), and PN concentrations are associated with increased systemic inflammation, platelet activation, and decreased circulating erythrocyte antioxidant enzyme activity in elderly people with CAD. Inactivation of antioxidant enzymes may be one mechanism of air pollutant–related increases in systemic inflammation. These effects may be partly behind reported morbidity and mortality associations with ambient PM2.5 mass concentrations (Pope and Dockery 2006). Stronger associations during the cooler phase of study, despite similar PM0.25 mass concentrations in cooler and warmer phases, further support the view that the greatest impacts on systemic responses may be attributable to nanoparticles not adequately represented by the present particle mass measurements as well as to unmeasured toxic air pollutants that increase near ground level in the winter. Our related experimental work using particles collected in the LA air basin at the Southern California Particle Center suggests that this might include redox active and electrophilic organic components of traffic exhaust particles in the ultrafine range (Araujo et al. 2008; Gong et al. 2007; Li et al. 2003; Ntziachristos et al. 2007; Shinyashiki et al. 2008). Footnotes Supplemental Material is available online (doi:10.1289/ehp.0800194.S1 via http://dx.doi.org/). We thank staff from the Department of Epidemiology and General Clinical Research Center, University of California Irvine, Department of Civil and Environmental Engineering, University of Southern California, the California Air Resources Board, and the South Coast Air Quality Management District. This project was supported by grant ES12243 from the National Institute of Environmental Health Sciences and grant MO1 RR00827 from the National Center for Research Resources, National Institutes of Health; the U.S. Environmental Protection Agency STAR grant RD83241301 to the University of California, Los Angeles; and the California Air Resources Board contract 03-329. The contents are solely the responsibility of the authors and do not necessarily represent the official views of the funding agencies, and no official endorsement should be inferred. References
|
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||||||||
J Air Waste Manag Assoc. 2006 Jun; 56(6):709-42.
[J Air Waste Manag Assoc. 2006]Inhal Toxicol. 2007; 19 Suppl 1():81-9.
[Inhal Toxicol. 2007]Part Fibre Toxicol. 2007 Jun 7; 4():5.
[Part Fibre Toxicol. 2007]Environ Health Perspect. 2003 Apr; 111(4):455-60.
[Environ Health Perspect. 2003]Clin Occup Environ Med. 2006; 5(4):785-96.
[Clin Occup Environ Med. 2006]Environ Health Perspect. 2005 Aug; 113(8):934-46.
[Environ Health Perspect. 2005]Environ Health Perspect. 2005 Aug; 113(8):947-55.
[Environ Health Perspect. 2005]Circulation. 2005 Nov 15; 112(20):3073-9.
[Circulation. 2005]Am J Cardiol. 2007 Mar 15; 99(6):808-12.
[Am J Cardiol. 2007]N Engl J Med. 2004 Dec 16; 351(25):2599-610.
[N Engl J Med. 2004]Environ Health Perspect. 2008 Jul; 116(7):898-906.
[Environ Health Perspect. 2008]Environ Health Perspect. 2005 Aug; 113(8):947-55.
[Environ Health Perspect. 2005]Environ Health Perspect. 2008 Jul; 116(7):898-906.
[Environ Health Perspect. 2008]Semin Thromb Hemost. 2005; 31(4):381-92.
[Semin Thromb Hemost. 2005]Environ Sci Technol. 2006 Feb 1; 40(3):945-54.
[Environ Sci Technol. 2006]J Air Waste Manag Assoc. 2007 Mar; 57(3):366-79.
[J Air Waste Manag Assoc. 2007]Environ Health Perspect. 2005 Aug; 113(8):947-55.
[Environ Health Perspect. 2005]J Air Waste Manag Assoc. 2007 Mar; 57(3):366-79.
[J Air Waste Manag Assoc. 2007]Environ Health Perspect. 2006 Jul; 114(7):992-8.
[Environ Health Perspect. 2006]Am J Respir Crit Care Med. 2006 Feb 15; 173(4):432-41.
[Am J Respir Crit Care Med. 2006]Environ Health Perspect. 2008 Jul; 116(7):898-906.
[Environ Health Perspect. 2008]Am J Respir Crit Care Med. 2007 Aug 15; 176(4):370-6.
[Am J Respir Crit Care Med. 2007]Environ Health Perspect. 2006 Jul; 114(7):992-8.
[Environ Health Perspect. 2006]Am J Respir Crit Care Med. 2006 Feb 15; 173(4):432-41.
[Am J Respir Crit Care Med. 2006]Mutat Res. 2007 Aug 1; 621(1-2):50-60.
[Mutat Res. 2007]Clin Occup Environ Med. 2006; 5(4):785-96.
[Clin Occup Environ Med. 2006]Environ Health Perspect. 2003 Apr; 111(4):455-60.
[Environ Health Perspect. 2003]Environ Health Perspect. 2003 Apr; 111(4):455-60.
[Environ Health Perspect. 2003]Inhal Toxicol. 1999 Feb; 11(2):89-109.
[Inhal Toxicol. 1999]Am J Respir Crit Care Med. 2006 Dec 1; 174(11):1239-48.
[Am J Respir Crit Care Med. 2006]Environ Health Perspect. 2005 Aug; 113(8):934-46.
[Environ Health Perspect. 2005]Environ Health Perspect. 2006 Jul; 114(7):992-8.
[Environ Health Perspect. 2006]Am J Respir Crit Care Med. 2006 Feb 15; 173(4):432-41.
[Am J Respir Crit Care Med. 2006]J Am Coll Cardiol. 2004 Jun 2; 43(11):1982-8.
[J Am Coll Cardiol. 2004]Semin Thromb Hemost. 2005; 31(4):381-92.
[Semin Thromb Hemost. 2005]Arterioscler Thromb Vasc Biol. 2005 Aug; 25(8):1584-9.
[Arterioscler Thromb Vasc Biol. 2005]Circulation. 2007 Jul 31; 116(5):489-96.
[Circulation. 2007]Environ Health Perspect. 2005 Feb; 113(2):201-6.
[Environ Health Perspect. 2005]Environ Health Perspect. 2003 Apr; 111(4):455-60.
[Environ Health Perspect. 2003]Environ Sci Technol. 2006 Apr 15; 40(8):2805-11.
[Environ Sci Technol. 2006]Mech Ageing Dev. 1990 Feb 15; 51(3):283-97.
[Mech Ageing Dev. 1990]Environ Sci Technol. 2006 Jul 15; 40(14):4353-9.
[Environ Sci Technol. 2006]Clin Occup Environ Med. 2006; 5(4):785-96.
[Clin Occup Environ Med. 2006]Antioxid Redox Signal. 2006 Jul-Aug; 8(7-8):1205-16.
[Antioxid Redox Signal. 2006]Biochem Mol Biol Int. 1998 Dec; 46(5):857-65.
[Biochem Mol Biol Int. 1998]Am J Respir Crit Care Med. 2004 Oct 15; 170(8):891-7.
[Am J Respir Crit Care Med. 2004]Am J Respir Crit Care Med. 2001 Jan; 163(1):201-9.
[Am J Respir Crit Care Med. 2001]Toxicol Sci. 2005 Jun; 85(2):898-905.
[Toxicol Sci. 2005]J Air Waste Manag Assoc. 2006 Jun; 56(6):709-42.
[J Air Waste Manag Assoc. 2006]Circ Res. 2008 Mar 14; 102(5):589-96.
[Circ Res. 2008]Genome Biol. 2007; 8(7):R149.
[Genome Biol. 2007]Environ Health Perspect. 2003 Apr; 111(4):455-60.
[Environ Health Perspect. 2003]Part Fibre Toxicol. 2007 Jun 7; 4():5.
[Part Fibre Toxicol. 2007]Environ Health Perspect. 2003 Apr; 111(4):455-60.
[Environ Health Perspect. 2003]